VFA
MGNX icon

Virtus Fund Advisers’s MacroGenics MGNX Stock Holding History

Virtus Fund Advisers’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$343K Buy
+18,057
New +$337K ﹤0.01% 417
2014
Q3 		– Sell
-1,704
Closed -$37K – 1598
2014
Q2 		$37K Buy
+1,704
New +$35.8K ﹤0.01% 2069

Other funds holding MGNX

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtus Fund Advisers's MGNX Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in MacroGenics (MGNX) in Q4 2017: 18,057 shares worth $343K. The stake represents ﹤0.01% of the portfolio and ranks #417 among its holdings. This is a return to the name: Virtus Fund Advisers previously reported a position in MGNX as recently as Q2 2014.

Virtus Fund Advisers first reported a position in MGNX in Q2 2014 and has held it in 2 quarters since. 119 funds tracked by Wall St. Rank hold MGNX as of Q4 2017.

  • Virtus Fund Advisers held 18,057 shares of MacroGenics worth $343K as of Q4 2017.
  • MacroGenics was a new Virtus Fund Advisers position in Q4 2017.
  • MacroGenics made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #417 holding.
  • Virtus Fund Advisers first reported a position in MacroGenics in Q2 2014 and has held it in 2 quarters since.
  • 119 funds tracked by Wall St. Rank held MacroGenics as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.